Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

492 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central nervous system involvement in diffuse large B-cell lymphoma.
Yamamoto W, Tomita N, Watanabe R, Hattori Y, Nakajima Y, Hyo R, Hashimoto C, Motomura S, Ishigatsubo Y. Yamamoto W, et al. Among authors: ishigatsubo y. Eur J Haematol. 2010 Jul;85(1):6-10. doi: 10.1111/j.1600-0609.2010.01438.x. Epub 2010 Mar 3. Eur J Haematol. 2010. PMID: 20236301
Secondary central nervous system lymphoma.
Tomita N, Kodama F, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: ishigatsubo y. Int J Hematol. 2006 Aug;84(2):128-35. doi: 10.1532/IJH97.06091. Int J Hematol. 2006. PMID: 16926134 Review.
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Hatta Y, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Ishigatsubo Y, Takeuchi K. Tomita N, et al. Among authors: ishigatsubo y. Cancer Sci. 2012 Feb;103(2):245-51. doi: 10.1111/j.1349-7006.2011.02139.x. Epub 2011 Nov 29. Cancer Sci. 2012. PMID: 22044593 Free article.
Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma.
Takemura S, Tomita N, Koharazawa H, Fujimaki K, Harano H, Hyo R, Yamazaki E, Hashimoto C, Miyazaki T, Ishigatsubo Y. Takemura S, et al. Among authors: ishigatsubo y. Int J Hematol. 2012 Aug;96(2):241-6. doi: 10.1007/s12185-012-1119-5. Epub 2012 Jun 10. Int J Hematol. 2012. PMID: 22684897 Clinical Trial.
Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era.
Takahashi H, Tomita N, Sakata S, Tsuyama N, Hashimoto C, Ohshima R, Matsuura S, Ogawa K, Yamamoto W, Kameda Y, Enaka M, Inayama Y, Kasahara M, Takekawa Y, Onoda N, Motomura S, Ishigatsubo Y, Takeuchi K. Takahashi H, et al. Among authors: ishigatsubo y. Eur J Haematol. 2013 Apr;90(4):286-90. doi: 10.1111/ejh.12075. Epub 2013 Mar 7. Eur J Haematol. 2013. PMID: 23331211 Clinical Trial.
R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y. Tomita N, et al. Among authors: ishigatsubo y. Br J Haematol. 2013 May;161(3):383-8. doi: 10.1111/bjh.12281. Epub 2013 Feb 25. Br J Haematol. 2013. PMID: 23432318 Free article.
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age.
Takasaki H, Hashimoto C, Fujita A, Matsumoto K, Taguchi J, Kuwabara H, Yamazaki E, Koharazawa H, Fujita H, Fujisawa S, Ishii Y, Yamamoto W, Motomura S, Tomita N, Ishigatsubo Y, Sakai R. Takasaki H, et al. Among authors: ishigatsubo y. Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):404-9. doi: 10.1016/j.clml.2013.03.003. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763919
492 results